Leadership
Zhang Lei — Founder & Chief Executive Officer
Glunova Biotech LLC was founded by Zhang Lei, who holds a Master’s degree in Biochemical Engineering from Zhejiang University of Technology, where he studied under Professor Yang Gensheng of the School of Pharmacy. Zhang Lei brings 15+ years of operational experience in pharmaceutical supply chain and research compound distribution across China, Singapore, and US group entities.
Professional profile: LinkedIn
Our Story
Glunova Biotech’s roots trace back to a Chinese pharmaceutical group established in 2014, which built domain expertise in research compound sourcing, quality verification, and international shipping. As global demand for compliance-grade research peptide supply grew, Glunova Biotech LLC was formally established as a US entity in 2024 (registered in Texas) to serve as the dedicated North American and international supply arm for research-grade peptides. We operate alongside a Singapore-based group affiliate to support compliance-driven distribution into APAC and EU markets.
Group Affiliations & Certifications
Our Singapore group affiliate, MARTHA TRADE PTE LTD, holds a current SOCOTEC Certification (Cert No. SCS 103915G) under SS 620:2016 (2021) — Good Distribution Practice for Medical Devices, issued by SOCOTEC Certification Singapore Pte Ltd, an SAC-accredited certification body (GDPMDS-2008-02). The certified scope covers import, storage, and distribution of medical devices through the affiliate’s Singapore facilities (Marina Bay business address; Bukit Batok storage site).
While this specific certification governs medical-device distribution at MARTHA TRADE PTE LTD, it reflects our group’s standing commitment to internationally-audited supply-chain practices. The same operational disciplines — documented receipt, segregated storage, controlled handling, and lot traceability — inform the quality framework Glunova Biotech LLC applies to research-grade peptide distribution.
Certificate validity: 01 October 2025 – 30 September 2028. Verifiable via SOCOTEC Singapore.
Academic Foundation
Our founder’s research background is rooted in graduate-level training at Zhejiang University of Technology‘s School of Pharmacy, under Professor Yang Gensheng. Prof. Yang’s research interests include pharmaceutical formulations, drug delivery systems, targeted drug delivery, and oncological applications. This academic grounding shapes Glunova Biotech’s emphasis on analytical rigor, per-lot documentation, and reproducibility in compound characterization across our research peptide portfolio.
Who We Are
Glunova Biotech LLC is a registered US limited liability company headquartered in Austin, Texas. We are a professional B2B distributor of research-grade peptides, serving the international scientific community — including research universities, contract research organizations (CROs), and independent biotech R&D laboratories worldwide.
Our focus is on reliable supply of high-purity research compounds with full documentation transparency, enabling researchers to conduct reproducible, well-characterized investigations.
What We Do
Glunova Biotech sources and distributes research-grade peptides across multiple active investigation domains:
- Metabolic & GLP-1 Research — GLP-1 receptor agonist peptides studied for metabolic pathway investigation
- Regenerative & Tissue Repair Research — Peptides including BPC-157, TB-500, and KPV studied in wound healing and tissue remodeling literature
- Growth Hormone Secretagogue Research — CJC-1295, Ipamorelin, Sermorelin, GHRP-6, Tesamorelin, and related compounds
- Mitochondrial & Cellular Research — SS-31, MOTS-C, NAD+, and IGF1-LR3 peptides studied in cellular energetics and aging research
- Neuropeptide Research — Selank, Thymosin Alpha-1, PT-141, and related compounds
- Skin & Cosmetic Research — GHK-Cu copper peptide for dermatological and wound-healing investigation
All compounds are supplied exclusively for in vitro research and laboratory investigation purposes.
Quality Framework
We maintain an ISO-aligned quality control process to ensure consistent purity and identity verification for every lot we release:
- HPLC Purity Verification — High-performance liquid chromatography analysis targeting ≥99% purity for each lot
- Mass Spectrometry ID Confirmation — Molecular weight and identity confirmed by mass spec analysis
- Endotoxin Testing — Bacterial endotoxin levels tested and documented per lot
- Certificate of Analysis (COA) Per Lot — Full analytical documentation issued with every shipment, including HPLC chromatogram, mass spec data, and endotoxin results
- Lot Traceability — Each lot tracked from synthesis through QC release to final shipment, enabling full chain-of-custody documentation
We work with third-party analytical laboratories for independent verification of purity and identity claims.
Logistics & Shipping
Research peptides require careful handling throughout the supply chain. Glunova Biotech manages cold-chain logistics with the following safeguards:
- Temperature-Controlled Shipping — Products shipped under cold-chain conditions appropriate for peptide stability
- Temperature Monitoring Loggers — Data loggers included with shipments to record temperature exposure during transit
- US Export Documentation — Full customs and export documentation prepared for international shipments from the United States
- Estimated Transit — 5–10 business days to major research markets globally, subject to customs clearance timelines
Who We Serve
Glunova Biotech operates exclusively on a B2B basis, serving verified research institutions and organizations:
- Research universities and academic laboratories
- Contract research organizations (CROs)
- Biotech and pharmaceutical R&D departments
- Independent peptide research laboratories
- Government and nonprofit research institutes
We do not sell to individuals for personal use. All orders require institutional or business verification.
Compliance & Intended Use
For Research Use Only. Not for human or veterinary use.
All compounds distributed by Glunova Biotech LLC are intended solely for in vitro scientific research and laboratory investigation. They are not approved for, nor intended for, diagnostic, therapeutic, or any other use in humans or animals. Researchers are responsible for compliance with all applicable local, national, and international regulations governing the use of research compounds in their jurisdiction.